Found: 94
Select item for more details and to access through your institution.
Metabolic dysfunction‐associated steatotic liver disease criteria may underestimate the number of lean female nonalcoholic fatty liver disease patients with significant liver fibrosis.
- Published in:
- Hepatology Research, 2024, v. 54, n. 5, p. 429, doi. 10.1111/hepr.13994
- By:
- Publication type:
- Article
Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study.
- Published in:
- Hepatology Research, 2024, v. 54, n. 4, p. 382, doi. 10.1111/hepr.13991
- By:
- Publication type:
- Article
Geriatric nutritional risk index as an easy‐to‐use assessment tool for nutritional status in hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
- Published in:
- Hepatology Research, 2023, v. 53, n. 10, p. 1031, doi. 10.1111/hepr.13934
- By:
- Publication type:
- Article
Association of proton pump inhibitor and antibiotic use with the clinical outcomes of hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: A multicenter analysis.
- Published in:
- Hepatology Research, 2023, v. 53, n. 8, p. 737, doi. 10.1111/hepr.13905
- By:
- Publication type:
- Article
Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice.
- Published in:
- Hepatology Research, 2022, v. 52, n. 9, p. 773, doi. 10.1111/hepr.13797
- By:
- Publication type:
- Article
Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 5, p. 462, doi. 10.1111/hepr.13748
- By:
- Publication type:
- Article
Time‐course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 3, p. 235, doi. 10.1111/hepr.13739
- By:
- Publication type:
- Article
Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC‐B stage patients classified as beyond up to seven criteria – Multicenter analysis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 3, p. 308, doi. 10.1111/hepr.13734
- By:
- Publication type:
- Article
Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression.
- Published in:
- Hepatology Research, 2021, v. 51, n. 8, p. 880, doi. 10.1111/hepr.13644
- By:
- Publication type:
- Article
Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 209, doi. 10.1159/000527402
- By:
- Publication type:
- Article
What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355
- By:
- Publication type:
- Article
The Significance of Zinc in Patients with Chronic Liver Disease.
- Published in:
- Nutrients, 2022, v. 14, n. 22, p. 4855, doi. 10.3390/nu14224855
- By:
- Publication type:
- Article
Metabolic Syndrome and Sarcopenia.
- Published in:
- Nutrients, 2021, v. 13, n. 10, p. 3519, doi. 10.3390/nu13103519
- By:
- Publication type:
- Article
Volumetric and Functional Regeneration of Remnant Liver With Massive Ascites After Hepatectomy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Placement of a 6 mm, fully covered metal stent for main pancreatic head duct stricture due to chronic pancreatitis: a pilot study (with video).
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 5, p. 722, doi. 10.1177/1756283X16651855
- By:
- Publication type:
- Article
EUS-guided FNA for biliary disease as first-line modality to obtain histological evidence.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 3, p. 302, doi. 10.1177/1756283X15625584
- By:
- Publication type:
- Article
EUS-guided cholecystoduodenostomy for acute cholecystitis with an anti-stent migration and anti-food impaction system; a pilot study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 1, p. 19, doi. 10.1177/1756283X15609285
- By:
- Publication type:
- Article
Diabetes mellitus does not influence results of hepatectomy in hepatocellular carcinoma: case control study.
- Published in:
- Contemporary Oncology / Współczesna Onkologia, 2020, v. 24, n. 4, p. 211, doi. 10.5114/wo.2020.102825
- By:
- Publication type:
- Article
Hepatectomy and liver regeneration in the results of treatment of colorectal liver metastasis.
- Published in:
- Contemporary Oncology / Współczesna Onkologia, 2020, v. 24, n. 3, p. 172, doi. 10.5114/wo.2020.100272
- By:
- Publication type:
- Article
Laparoscopic liver resection for patients with cardiac disease.
- Published in:
- Contemporary Oncology / Współczesna Onkologia, 2019, v. 23, n. 1, p. 37, doi. 10.5114/wo.2019.84109
- By:
- Publication type:
- Article
The utility of the subcuticular suture in hepatic resection.
- Published in:
- Contemporary Oncology / Współczesna Onkologia, 2018, v. 22, n. 3, p. 184, doi. 10.5114/wo.2018.78940
- By:
- Publication type:
- Article
The Management of Recurrence within Six Months after Hepatic Resection for Colorectal Liver Metastasis.
- Published in:
- Digestive Surgery, 2020, v. 37, n. 4, p. 282, doi. 10.1159/000503420
- By:
- Publication type:
- Article
Therapeutic efficacy of ramucirumab after lenvatinib for post-progression treatment of unresectable hepatocellular carcinoma.
- Published in:
- Gastroenterology Report, 2021, v. 9, n. 2, p. 133, doi. 10.1093/gastro/goaa042
- By:
- Publication type:
- Article
Cancer Cachexia: Its Mechanism and Clinical Significance.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 16, p. 8491, doi. 10.3390/ijms22168491
- By:
- Publication type:
- Article
Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 14, p. 4939, doi. 10.3390/ijms21144939
- By:
- Publication type:
- Article
Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate‐stage hepatocellular carcinoma.
- Published in:
- Liver International, 2024, v. 44, n. 1, p. 113, doi. 10.1111/liv.15753
- By:
- Publication type:
- Article
Neutrophil‐to‐lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Liver International, 2020, v. 40, n. 4, p. 968, doi. 10.1111/liv.14405
- By:
- Publication type:
- Article
Sequential therapy involving an early switch from entecavir to pegylated interferon‐α in Japanese patients with chronic hepatitis B.
- Published in:
- Hepatology Research, 2018, v. 48, n. 6, p. 459, doi. 10.1111/hepr.13050
- By:
- Publication type:
- Article
Risk Factors for Nephrotoxicity due to Tacrolimus Therapy for Ulcerative Colitis.
- Published in:
- Digestion, 2022, v. 103, n. 5, p. 339, doi. 10.1159/000524594
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring of Golimumab for the Prediction of Long-Term Clinical Remission in Patients with Ulcerative Colitis.
- Published in:
- Digestion, 2022, v. 103, n. 5, p. 329, doi. 10.1159/000524593
- By:
- Publication type:
- Article
Endoscopic Diagnosis of the Invasion Depth of T1 Colorectal Carcinoma for Endoscopic Resection by Using Narrow-Band Imaging Magnification as Total Excisional Biopsy.
- Published in:
- Digestion, 2016, v. 94, n. 2, p. 106, doi. 10.1159/000449284
- By:
- Publication type:
- Article
Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.
- Published in:
- Oncology, 2023, v. 101, n. 10, p. 624, doi. 10.1159/000531316
- By:
- Publication type:
- Article
Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.
- Published in:
- Oncology, 2023, v. 101, n. 9, p. 542, doi. 10.1159/000530028
- By:
- Publication type:
- Article
Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.
- Published in:
- Oncology, 2023, v. 101, n. 4, p. 270, doi. 10.1159/000527676
- By:
- Publication type:
- Article
Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology, 2022, v. 100, n. 12, p. 645, doi. 10.1159/000526521
- By:
- Publication type:
- Article
Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.
- Published in:
- Oncology, 2021, v. 99, n. 8, p. 518, doi. 10.1159/000515896
- By:
- Publication type:
- Article
Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology, 2020, v. 98, n. 5, p. 295, doi. 10.1159/000506293
- By:
- Publication type:
- Article
Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
- Published in:
- Cancer Reports, 2024, v. 7, n. 4, p. 1, doi. 10.1002/cnr2.2042
- By:
- Publication type:
- Article
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience.
- Published in:
- Cancer Reports, 2022, v. 5, n. 2, p. 1, doi. 10.1002/cnr2.1464
- By:
- Publication type:
- Article
Enhancement of O-linked N-acetylglucosamine modification promotes metastasis in patients with colorectal cancer and concurrent type 2 diabetes mellitus.
- Published in:
- Oncology Letters, 2020, v. 20, n. 2, p. 1171, doi. 10.3892/ol.2020.11665
- By:
- Publication type:
- Article
Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 233, doi. 10.1111/apt.18037
- By:
- Publication type:
- Article
The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 9, p. 1230, doi. 10.1111/apt.15218
- By:
- Publication type:
- Article
Characteristics of cabozantinib treatment in advanced hepatocellular carcinoma.
- Published in:
- Liver Cancer International, 2023, v. 4, n. 3, p. 101, doi. 10.1002/lci2.74
- By:
- Publication type:
- Article
Two healthy females with fulminant hepatic failure caused by herpes simplex virus infection.
- Published in:
- Pathology International, 2014, v. 64, n. 1, p. 48, doi. 10.1111/pin.12128
- By:
- Publication type:
- Article
Increased both PD–L1 and PD–L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-67497-2
- By:
- Publication type:
- Article
Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study.
- Published in:
- Infectious Diseases & Therapy, 2020, v. 9, n. 4, p. 851, doi. 10.1007/s40121-020-00329-y
- By:
- Publication type:
- Article
Dysbiosis and liver diseases (Review).
- Published in:
- International Journal of Molecular Medicine, 2021, v. 48, n. 3, p. N.PAG, doi. 10.3892/ijmm.2021.5016
- By:
- Publication type:
- Article
Pathophysiology and mechanisms of primary sarcopenia (Review).
- Published in:
- International Journal of Molecular Medicine, 2021, v. 48, n. 2, p. N.PAG, doi. 10.3892/ijmm.2021.4989
- By:
- Publication type:
- Article
A long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, as a preventive drug for the development of hepatic steatosis in high-fructose diet-fed ob/ob mice.
- Published in:
- International Journal of Molecular Medicine, 2017, v. 39, n. 4, p. 969, doi. 10.3892/ijmm.2017.2899
- By:
- Publication type:
- Article
Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice.
- Published in:
- International Journal of Molecular Medicine, 2016, v. 38, n. 5, p. 1499, doi. 10.3892/ijmm.2016.2766
- By:
- Publication type:
- Article